Determinants of Achieving Serum Urate Goal with Treat‐to‐Target Urate‐Lowering Therapy in Gout
LN Helget, JR O'Dell, JA Newcomb… - Arthritis & …, 2024 - Wiley Online Library
Objective Using trial data comparing treat‐to‐target allopurinol and febuxostat in gout, we
examined participant characteristics associated with serum urate (SU) goal achievement …
examined participant characteristics associated with serum urate (SU) goal achievement …
The development and evaluation of dose‐prediction tools for allopurinol therapy (Easy‐Allo tools)
DFB Wright, HZ Hishe, SL Stocker… - British Journal of …, 2024 - Wiley Online Library
Aims Dose escalation at the initiation of allopurinol therapy can be protracted and resource
intensive. Tools to predict the allopurinol doses required to achieve target serum urate …
intensive. Tools to predict the allopurinol doses required to achieve target serum urate …
[PDF][PDF] Medication adherence research comes of age
DFB Wright, KA Sinnappah… - British journal of clinical …, 2023 - research.bangor.ac.uk
Suboptimal medication adherence has been recognised since antiquity as a major 1
determinant of poor health outcomes. Hippocrates warned physicians that patients might “lie …
determinant of poor health outcomes. Hippocrates warned physicians that patients might “lie …
Urinary oxypurinol is a useful tool to assess adherence to allopurinol in clinical practice
L Hasikova, J Bartl, B Stiburkova - Rheumatology, 2024 - academic.oup.com
DEAR EDITOR, Gout is the most prevalent inflammatory arthritis worldwide; however, it is
known that the adherence to urate-lowering therapy is often poor. The xanthine oxidase …
known that the adherence to urate-lowering therapy is often poor. The xanthine oxidase …